NASDAQ
Eloxx Pharmaceuticals, Inc. (ELOX) has a revenue compound annual growth rate of -11.74% over 5 years and 1.18% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.